Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG Treatment in Children With PANS
NCT04609761Phase 2Completed
- Sponsor
- University of Gothenburg
- Start
- Jan 2021
- Primary completion
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in pediatric acute-onset neuropsychiatric syndrome (PANS), sponsored by University of Gothenburg. Started Jan 2021; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
pediatric acute-onset neuropsychiatric syndrome (PANS)
Beyond the preview
Go deeper on NCT04609761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04609761.